Case report: intravenous etidronate as a cause of poor uptake on bone scanning, with a review of the literature.
Bone scanning is the most frequent type of radionuclide examination performed. We present a case of reduced uptake on a bone scan thought to be due to etidronate therapy. Other causes of this phenomenon are reviewed.
Chong
W K
WK
Department of Radiology, St Mary's Hospital, London.
Cunningham
D A
DA
D000368:Aged; D001416:Back Pain / Q000000981:diagnostic imaging; D001842:Bone and Bones / Q000000981:diagnostic imaging / Q000187:drug effects / Q000378:metabolism*; D012968:Etidronic Acid / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging; D008297:Male; D011877:Radionuclide Imaging; D013669:Technetium Tc 99m Medronate / Q000378:metabolism
D012968:Etidronic Acid; D013669:Technetium Tc 99m Medronate